Heparanase expression correlates with poor survival in oral mucosal melanoma

Medical Oncology

Volumn 30, Issue 3, 2013, Pages

  Wang, Xin ^a   Wen, Weiwei ^b   Wu, Heming ^c   Chen, Yi ^b   Ren, Guoxin ^d   Guo, Wei ^d  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Heparanase; Localization; Oral mucosal melanoma; Staining; Survival

Indexed keywords

HEPARANASE; BETA GLUCURONIDASE;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH MUCOSA; MOUTH TUMOR; ORAL MUCOSAL DISEASE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; GENETICS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS;

FEMALE; GLUCURONIDASE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 84879052925     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0633-5     Document Type: Article

References (29)

1. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the US. Cancer. 2005;103(5):1000-7. doi:10.1002/cncr.20866.
2. Sortino-Rachou AM, Cancela Mde C, Voti L, Curado MP. Primary oral melanoma: population-based incidence. Oral Oncol. 2009;45(3):254-8. doi:10.1016/j.oraloncology.2008.04.015.
3. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135-47. doi:10.1056/NEJMoa050092.
4. Lourenco SV, Sotto MN, Bologna SB, Giacomo TB, Buim ME, et al. Primary oral mucosal melanoma: a series of 35 new cases from South America. Am J Dermatopathol. 2009;31(4):323-30. doi:10.1097/DAD.0b013e3181a0d37c.
5. Bachar G, Loh KS, O'Sullivan B, Goldstein D, Wood S, Brown D, et al. Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital. Head Neck. 2008;30(10):1325-31. doi:10.1002/hed.20878.
6. McLean N, Tighiouart M, Muller S. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. Oral Oncol. 2008;44(11):1039-46. doi:10.1016/j.oraloncology.2008.01.014.
7. Engbring JA, Kleinman HK. The basement membrane matrix in malignancy. J Pathol. 2003;200(4):465-70. doi:10.1002/path.1396.
8. Roy M, Marchetti D. Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis. J Cell Biochem. 2009;106(2):200-9. doi:10.1002/jcb.22005.
9. Nagler R, Ben-Izhak O, Cohen-Kaplan V, Shafat I, Vlodavsky I, Akrish S, et al. Heparanase up-regulation in tongue cancer: tissue and saliva analysis. Cancer. 2007;110(12):2732-9. doi:10.1002/cncr. 23095.
10. Davidson B, Shafat I, Risberg B, Ilan N, Trope CG, Vlodavsky I, et al. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma. Gynecol Oncol. 2007;104(2): 311-9. doi:10.1016/j.ygyno.2006.08.045.
11. Lerner I, Baraz L, Pikarsky E, Meirovitz A, Edovitsky E, Peretz T, et al. Function of heparanase in prostate tumorigenesis: potential for therapy. Clin Cancer Res. 2008;14(3):668-76. doi: 10.1158/1078-0432.CCR-07-1866.
12. Cohen E, Doweck I, Naroditsky I, Ben-Izhak O, Kremer R, Best LA, et al. Heparanase is overexpressed in lung cancer and correlates inversely with patient survival. Cancer. 2008;113(5):1004-11. doi: 10.1002/cncr.23680.
13. Masola V, Maran C, Tassone E, Zin A, Rosolen A, Onisto M. Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion. BMC Cancer. 2009;9:304. doi: 10.1186/1471-2407-9-304.
14. Shafat I, Pode D, Peretz T, Ilan N, Vlodavsky I, Nisman B. Clinical significance of urine heparanase in bladder cancer progression. Neoplasia. 2008;10(2):125-30.
15. Mikami S, Oya M, Shimoda M, Mizuno R, Ishida M, Kosaka T, et al. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis. Clin Cancer Res. 2008;14(19):6055-61. doi:10.1158/1078-0432.CCR-08-0750.
16. Edge SB, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
17. Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, et al. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci. 2004;117(Pt 11):2249-58. doi:10.1242/jcs.01068.
18. Kruse AL, Riener MO, Graetz KW, Luebbers HT. Mucosal malignant melanomas in head and neck surgery: a retrospective study of six patients and review of the literature. Oral Maxillofac Surg. 2010;. doi:10.1007/s10006-010-0207-z.
19. Mucke T, Holzle F, Kesting MR, Loeffelbein DJ, Robitzky LK, Hohlweg-Majert B, et al. Tumor size and depth in primarymalignant melanoma in the oral cavity influences survival. J Oral Maxillofac Surg. 2009;67(7):1409-15. doi:10.1016/j.joms.2008.12.021.
20. Moreno MA, Hanna EY. Management of mucosal melanomas of the head and neck: did we make any progress? Curr Opin Otolaryngol Head Neck Surg. 2010;18(2):101-6. doi:10.1097/MOO. 0b013e3283374d31.
21. Collins RJ. Melanoma in the Chinese of Hong Kong. Emphasis on volar and subungual sites. Cancer. 1984;54(7):1482-8.
22. Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancermetastasis and angiogenesis. Int J Biochem Cell Biol. 2006;38(12):2018-39. doi:10.1016/j.biocel. 2006.06.004.
23. Vlodavsky I, Abboud-Jarrous G, Elkin M, Naggi A, Casu B, Sasisekharan R, et al. The impact of heparanase and heparin on cancer metastasis and angiogenesis. Pathophysiol Haemost Thromb. 2006;35(1-2):116-27. doi:10.1159/000093553.
24. Zhang Y, Ryan DS, Bower KS, Ilan N, Vlodavsky I, Laurie GW. Focus on Molecules: Heparanase. Exp Eye Res. doi:10.1016/j.exer.2010.05.004.
25. Vlodavsky I, Elkin M, Abboud-Jarrous G, Levi-Adam F, Fuks L, Shafat I, et al. Heparanase: one molecule with multiple functions in cancer progression. Connect Tissue Res. 2008;49(3):207-10. doi:10.1080/03008200802143281.
26. Leiser Y, Abu-El-Naaj I, Sabo E, Akrish S, Ilan N, Ben-Izhak O et al. Prognostic value of heparanase expression and cellular localization in oral cancer. Head Neck. doi:10.1002/hed.21545.
27. Rivera RS, Nagatsuka H, Siar CH, Gunduz M, Tsujigiwa H, Han PP, et al. Heparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma. Oncol Rep. 2008;19(3):657-61.
28. Doweck I, Kaplan-Cohen V, Naroditsky I, Sabo E, Ilan N, Vlodavsky I. Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival. Neoplasia. 2006;8(12):1055-61. doi:10.1593/neo.06577.
29. Ohkawa T, Naomoto Y, Takaoka M, Nobuhisa T, Noma K, Motoki T, et al. Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation. Lab Invest. 2004;84(10):1289-304. doi:10.1038/labinvest.3700159.